COLL vs WELL · P/E 17, rev $181.9M vs P/E 100, rev $10.84B
Collegium Pharmaceutical Inc (COLL) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the COLL and WELL stock pages for the full models.
Not investment advice.